financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Tesla Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Tesla Inc.
Jun 13, 2024 5:34 AM

08:10 AM EDT, 06/13/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target by $20 to $230, based on a '25 P/E of 60x, justified by long-term growth expectations. TSLA shares are trading higher in the pre-market after CEO Elon Musk posted on X that the reapproval of his 2018 pay package and its corporate relocation to Texas from Delaware were passing "by wide margins." We consider this good news for TSLA investors and attribute the success of the proposals to the overwhelming support of TSLA's large retail investor base, who collectively own ~40% of the shares, combined with a portion of its fragmented institutional investor base (only two funds own more than 4%) where support was more divided. If approved later today, we think it would lift a major near-term overhang on the stock, as investors send a strong message of "staying the course." In our view, Musk has delivered for shareholders over the past 5-6 years, meeting the lofty thresholds of his entirely incentive-based compensation plan and there's little reason to doubt this won't continue.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Sell Opinion On Shares Of Posco Holdings
Research Alert: CFRA Maintains Sell Opinion On Shares Of Posco Holdings
May 26, 2025
03:10 PM EDT, 05/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price to USD36 from USD34, valuing the stock at 0.30x 2025 P/BV, 40% below its five-year mean. We project revenue to decline by 2% in 2025...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Vistra Corp.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Vistra Corp.
May 26, 2025
01:10 PM EDT, 05/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target $20 to $180, 28.5x our 2025 EPS estimate (down $0.22 to $6.31; we cut 2026 by $0.32 to $8.08), a premium to fully-regulated peers given...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Aptargroup, Inc.
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Aptargroup, Inc.
May 26, 2025
03:30 PM EDT, 05/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target by $4 to $177, valuing ATR at 28.2x our 2025 EPS estimate, a discount to ATR's five-year average forward P/E of 28.8x. Our multiple is...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Unitedhealth Group Incorporated
Research Alert: CFRA Keeps Sell Opinion On Shares Of Unitedhealth Group Incorporated
May 26, 2025
02:35 PM EDT, 05/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We slash our 12-month target price to $285 from $379, 10.8x our 2025 EPS estimate, a discount to UNH's historical forward average due to regulatory uncertainty and unfavorable care-related trends...
Copyright 2023-2026 - www.financetom.com All Rights Reserved